Arcellx Inc ACLX

NAS: ACLX | ISIN: US03940C1009 20/06/2025

63,00 USD (-1,28%)

(-1,28%) 20/06/2025

Grafiek Arcellx Inc

Grafiek Arcellx Inc

1 dag1d -1,28%
1 week1w -1,70%
1 maand1m -3,88%
3 maanden3m -9,13%
6 maanden6m -17,96%
1 jaar1j 12,26%
5 jaar5j 275,00%

Arcellx Inc in het nieuws

Toon enkel gratis nieuws

29 februari 2024 · Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference · Persbericht

28 februari 2024 · Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights · Persbericht

8 december 2023 · Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH · Persbericht

2 november 2023 · Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and Exposition · Persbericht

26 oktober 2023 · Arcellx to Participate in Two Upcoming Investor Conferences · Persbericht

14 augustus 2023 · Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results · Persbericht

20 juni 2023 · Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program · Persbericht

8 mei 2023 · Arcellx Provides First Quarter Financial Results · Persbericht

13 april 2023 · Arcellx to Participate at the Canaccord Genuity 2023 Horizons in Oncology Virtual Conference · Persbericht

29 maart 2023 · Arcellx Provides Fourth Quarter and Year-End 2022 Financial Results and Business Highlights · Persbericht

Profiel Arcellx Inc

Website: arcellx.com

Hoofdzetel: Gaithersburg, MD Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe